VEN+AZA+Modified BUCY
VA+mBUCY-02
Phase 2 small_molecule active
Quick answer
VEN+AZA+Modified BUCY for Allogeneic Hematopoietic Stem Cell Transplantation is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Allogeneic Hematopoietic Stem Cell Transplantation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active